Cargando…

Correction to: DDPD 1.0: a manually curated and standardized database of digital properties of approved drugs for drug-likeness evaluation and drug development

Detalles Bibliográficos
Autores principales:	Li, Qiang, Ma, Shiyong, Zhang, Xuelu, Zhai, Zhaoyu, Zhou, Lu, Tao, Haodong, Wang, Yachen, Pan, Jianbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216471/ https://www.ncbi.nlm.nih.gov/pubmed/35325082 http://dx.doi.org/10.1093/database/baac016

Ejemplares similares

DDPD 1.0: a manually curated and standardized database of digital properties of approved drugs for drug-likeness evaluation and drug development
por: Li, Qiang, et al.
Publicado: (2022)

Photodynamics of the Molecular Ruby [Cr(ddpd)(2)](3+)
por: Zobel, J. Patrick, et al.
Publicado: (2023)

PertOrg 1.0: a comprehensive resource of multilevel alterations induced in model organisms by in vivo genetic perturbation
por: Zhai, Zhaoyu, et al.
Publicado: (2022)

DrugMechDB: A Curated Database of Drug Mechanisms
por: Gonzalez-Cavazos, Adriana Carolina, et al.
Publicado: (2023)

DrugMechDB: A Curated Database of Drug Mechanisms
por: Gonzalez-Cavazos, Adriana Carolina, et al.
Publicado: (2023)

OrganoidDB: a comprehensive organoid database for the multi-perspective exploration of bulk and single-cell transcriptomic profiles of organoids
por: Ma, Qinfeng, et al.
Publicado: (2022)

Pre‐approval and post‐approval availability of evidence and clinical benefit of conditionally approved cancer drugs in Europe: A comparison with standard approved cancer drugs
por: Bloem, Lourens T., et al.
Publicado: (2022)

ILDGDB: a manually curated database of genomics, transcriptomics, proteomics and drug information for interstitial lung diseases
por: Li, Yupeng, et al.
Publicado: (2020)

Of the Drug Curative
por: Wells, P. P.
Publicado: (1890)

Of the Drug Curative
por: Wells, P. P.
Publicado: (1890)

Of the Drug Curative
por: Wells, P. P.
Publicado: (1890)

A curated and standardized adverse drug event resource to accelerate drug safety research
por: Banda, Juan M., et al.
Publicado: (2016)

ONRLDB—manually curated database of experimentally validated ligands for orphan nuclear receptors: insights into new drug discovery
por: Nanduri, Ravikanth, et al.
Publicado: (2015)

SWEETLEAD: an In Silico Database of Approved Drugs, Regulated Chemicals, and Herbal Isolates for Computer-Aided Drug Discovery
por: Novick, Paul A., et al.
Publicado: (2013)

A standard database for drug repositioning
por: Brown, Adam S., et al.
Publicado: (2017)

A ‘rule of 0.5’ for the metabolite-likeness of approved pharmaceutical drugs
por: O′Hagan, Steve, et al.
Publicado: (2014)

Manually curated database of rice proteins
por: Gour, Pratibha, et al.
Publicado: (2014)

Predictors of orphan drug approval
por: Heemstra, Harald
Publicado: (2010)

Repurposing of approved cardiovascular drugs
por: Ishida, Junichi, et al.
Publicado: (2016)

KinaseMD: kinase mutations and drug response database
por: Hu, Ruifeng, et al.
Publicado: (2020)

Cancer Drug Approvals That Displaced Existing Standard-of-Care Therapies, 2016-2021
por: Benjamin, David J., et al.
Publicado: (2022)

Virtual screening and drug repositioning of FDA-approved drugs from the ZINC database to identify the potential hTERT inhibitors
por: Afzaal, Hasan, et al.
Publicado: (2022)

Approvals in 2021: dangling Accelerated Approvals, drug dosing, new approvals and beyond
por: Lemery, Steven, et al.
Publicado: (2022)

Discrimination of approved drugs from experimental drugs by learning methods
por: Tang, Kailin, et al.
Publicado: (2011)

Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval
por: King, Emily A., et al.
Publicado: (2019)

The HIV drug optimization agenda: promoting standards for earlier investigation and approvals of antiretroviral drugs for use in adolescents living with HIV
por: Rojo, Pablo, et al.
Publicado: (2020)

The use of mechanistic evidence in drug approval
por: Aronson, Jeffrey K., et al.
Publicado: (2018)

Repurposing approved drugs for cancer therapy
por: Schein, Catherine H
Publicado: (2021)

Alchemical analysis of FDA approved drugs
por: Orsi, Markus, et al.
Publicado: (2023)

Computational prognostic evaluation of Alzheimer’s drugs from FDA-approved database through structural conformational dynamics and drug repositioning approaches
por: Hassan, Mubashir, et al.
Publicado: (2023)

DrugBank 5.0: a major update to the DrugBank database for 2018
por: Wishart, David S, et al.
Publicado: (2018)

Drugs, Devices, and the FDA: Part 1: An Overview of Approval Processes for Drugs
por: Van Norman, Gail A.
Publicado: (2016)

Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
por: Mao, Fei, et al.
Publicado: (2016)

Characteristics of Recent Generic Drug Approvals by the US Food and Drug Administration
por: Jiao, Kuo, et al.
Publicado: (2019)

An open science pathway for drug marketing authorization—Registered drug approval
por: Naudet, Florian, et al.
Publicado: (2021)

Use of Extrapolation in New Drug Approvals by the US Food and Drug Administration
por: Feldman, Daniel, et al.
Publicado: (2022)

VARIDT 1.0: variability of drug transporter database
por: Yin, Jiayi, et al.
Publicado: (2020)

VARIDT 1.0: variability of drug transporter database
por: Yin, Jiayi, et al.
Publicado: (2020)

CORDITE: The Curated CORona Drug InTERactions Database for SARS-CoV-2
por: Martin, Roman, et al.
Publicado: (2020)

DAMPD: a manually curated antimicrobial peptide database
por: Seshadri Sundararajan, Vijayaraghava, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_059ih9otf7uck5vumnhujaip9o